VaxartSTU:NB11 59 OCF Yield % is 10.22 as of Jul. 07, 2026. GuruFocus rates STU:NB11 with a GF Score™ of 59/100 and a GF Value™ of €8.33. The stock has 3 warning signs investors should review. Among 1,409 Biotechnology companies, Vaxart ranks better than 96.03% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Vaxart OCF Yield % Related Terms
Vaxart OCF Yield % Historical Data
* Premium members only.
The historical data trend for Vaxart's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:NB11 vs SPRO, ADCT, GNLX: OCF Yield % Comparison
For the Biotechnology subindustry, Vaxart's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaxart OCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vaxart's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Vaxart's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaxart (STU:NB11) has a OCF Yield % of 10.22 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vaxart and its competitors. According to the industry distribution chart, Vaxart ranks #56 out of 1409 companies in the Biotechnology industry, placing it in the top 4%.
Is Vaxart's OCF Yield % too high?
Vaxart's current OCF Yield % is 10.22. Based on the distribution chart, Vaxart ranks #56 out of 1409 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Vaxart has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Vaxart's OCF Yield % compare to SPRO and ADCT?
According to the Biotechnology industry distribution chart, Vaxart ranks #56 out of 1409 companies for OCF Yield %. This places Vaxart in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Vaxart and its competitors. Vaxart's current OCF Yield % is 10.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxart stock overvalued right now?
Vaxart (STU:NB11) has a current OCF Yield % of 10.22. The stock's GF Value™ is €8.33, compared to a current price of €0.60 — trading 92.8% below its estimated fair value. The current OCF Yield % is 10.22. Vaxart's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Vaxart (STU:NB11), the current OCF Yield % is 10.22 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaxart (STU:NB11) Overvalued in 2026?
Based on GuruFocus' analysis, Vaxart stock appears to be undervalued.
The current stock price of €0.60 is trading 92.8% below its estimated GF Value™ of €8.33.
Key valuation signals for STU:NB11:
OCF Yield %: 10.22
GF Value™: €8.33 vs. price of €0.60 (92.8% below fair value)
No single metric tells the full story. See the STU:NB11 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically, all the business activity functions through the region of the United States.
59GF Score
Get the complete analysis for STU:NB11
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:NB11 has been successfully added to your 
